Christopher W West

Discovery of selective urokinase plasminogen activator (uPA) inhibitors as a potential treatment for multiple sclerosis.

M. Adler, M. Whitlow, C. Mallari, 2018, Bioorganic & medicinal chemistry letters.

Identification of orally bioavailable, non-amidine inhibitors of Urokinase Plasminogen Activator (uPA).

M. Adler, M. Whitlow, R. Pulk, 2009, Bioorganic & medicinal chemistry letters.

Structures of potent selective peptide mimetics bound to carboxypeptidase B.

M. Adler, M. Whitlow, J. Morser, 2008, Acta crystallographica. Section D, Biological crystallography.

Differential Inhibition of Inducible T Cell Cytokine Secretion by Potent Iron Chelators

Hong-tao Lu, M. Berger, D. Schilling, 2005, Journal of biomolecular screening.